Suvretta Capital Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-75,000
| Closed | -$270K | – | 106 |
|
|
2024
Q2 | $270K | Sell |
75,000
-3,578,494
| -98% | -$12.9M | 0.01% | 93 |
|
|
2024
Q1 | $12.1M | Sell |
3,653,494
-3,717,344
| -50% | -$12.3M | 0.45% | 47 |
|
|
2023
Q4 | $17M | Buy |
7,370,838
+6,400
| +0.1% | +$14.8K | 0.77% | 38 |
|
|
2023
Q3 | $9.5M | Hold |
7,364,438
| – | – | 0.51% | 45 |
|
|
2023
Q2 | $9.72M | Hold |
7,364,438
| – | – | 0.52% | 51 |
|
|
2023
Q1 | $5.21M | Hold |
7,364,438
| – | – | 0.22% | 55 |
|
|
2022
Q4 | $5.52M | Hold |
7,364,438
| – | – | 0.23% | 56 |
|
|
2022
Q3 | $6.34M | Sell |
7,364,438
-1,777,629
| -19% | -$1.53M | 0.26% | 52 |
|
|
2022
Q2 | $10.2M | Hold |
9,142,067
| – | – | 0.39% | 55 |
|
|
2022
Q1 | $10.2M | Hold |
9,142,067
| – | – | 0.31% | 53 |
|
|
2021
Q4 | $14.6M | Hold |
9,142,067
| – | – | 0.28% | 56 |
|
|
2021
Q3 | $22.1M | Buy |
9,142,067
+492,767
| +6% | +$1.19M | 0.37% | 46 |
|
|
2021
Q2 | $27.4M | Buy |
8,649,300
+2,283,800
| +36% | +$7.24M | 0.41% | 53 |
|
|
2021
Q1 | $21.5M | Buy |
6,365,500
+3,616,501
| +132% | +$12.2M | 0.32% | 56 |
|
|
2020
Q4 | $9.84M | Buy |
+2,748,999
| New | +$9.84M | 0.14% | 62 |
|